Clinical trials: Breast Cancer Prevention
Breast Cancer, Liver Cancer
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
This proposal brings together multidisciplinary teams from four New York City institutions charged with reducing cancer disparities that affect approximately two million people residing in some of the most diverse and underserved…
- Conditions
- Breast Cancer, Liver Cancer, Prostate Cancer
- Trial name
- DISRUPT (NCT05146297)
- Testing
- Clinical trial match-list, Match-list intervention
- Where
- 3 sites in United States
- Volunteers
- 585 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Dietary and Lifestyle Behaviour Change
Personalised Behavioural Intervention in Cancer Screening Programmes
The aim of this clinical trial is to find out whether CANVIA can help adults improve dietary and lifestyle habits related to cancer prevention.
- Trial name
- CANVIA (NCT07722442)
- Testing
- Personalised baseline feedback report, CANVIA mobile app intervention, Additional health professional support
- Where
- Spain
- Volunteers
- 162 people, healthy volunteers welcome
- Sponsor
- Fundació d'investigació Sanitària de les Illes Balears
Breast Cancer
Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine
The purpose of this study is to look for ways to improve breast cancer treatment by giving breast cancer drugs through the skin of the breast.
- Trial name
- NCT01380353
- Testing
- Diclofenac epolamine patch
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Northwestern University
Cancer
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
RATIONALE: White blood cells from donors who have been exposed to cytomegalovirus may be able to help prevent this infection from occurring in patients who are undergoing bone marrow or peripheral stem cell transplantation.
- Trial name
- NCT00002673
- Testing
- infection prophylaxis and management
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Fred Hutchinson Cancer Center
Breast Cancer Risk, Ovarian Cancer Risk
Population Based Germline Testing for Early Detection and Prevention of Cancer
PROTECT-C is a research study offering genetic testing to people to see whether they have a genetic change that increases their risk of breast, ovary, bowel, and/or womb cancer.
- Conditions
- Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation
- Trial name
- PROTECT-C (NCT07498829)
- Testing
- Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) and personalised breast and ovarian cancer risk
- Where
- United Kingdom
- Volunteers
- 6,000 people, healthy volunteers welcome
- Sponsor
- Queen Mary University of London
Breast Cancer
Improving Cancer-Related Outcomes in Shift Workers
Shift work with circadian disruption has been linked with increased breast cancer incidence. The mechanisms for this effect are not yet completely understood.
- Trial name
- ICOS (NCT02609373)
- Testing
- Sleep intervention
- Where
- Canada
- Volunteers
- 47 people, healthy volunteers welcome
- Sponsor
- University of British Columbia
Cancer
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
RATIONALE: Giving itraconazole or fluconazole may be effective in preventing infections in patients undergoing peripheral stem cell or bone marrow transplantation.
- Trial name
- NCT00003883
- Testing
- fluconazole, itraconazole
- Where
- 2 sites in United States
- Volunteers
- 578 people
- Sponsor
- Fred Hutchinson Cancer Center
Breast Cancer
Breast Cancer - Anti-Progestin Prevention Study 1
The primary objective of this study is to determine the effects of the antiprogestin ulipristal acetate (UA) on the epithelial and stromal compartments of the normal breast in women at increased risk of breast cancer (BC) and to…
- Trial name
- BC-APPS1 (NCT02408770)
- Testing
- ulipristal acetate
- Where
- United Kingdom
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Manchester University NHS Foundation Trust
Breast Cancer, Cervical Cancer
Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care
RATIONALE: Women may stay up-to-date with cancer screening if a health professional helps them overcome barriers to screening, including helping them to schedule cancer screening appointments.
- Conditions
- Breast Cancer, Cervical Cancer, Colorectal Cancer
- Trial name
- NCT00477646
- Testing
- Prevention Care Management
- Where
- United States
- Volunteers
- 2,241 people
- Sponsor
- Dartmouth-Hitchcock Medical Center
Ductal Carcinoma in Situ
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Women with biopsy-proven ductal carcinoma in situ (DCIS) will be enrolled into two cohorts. One cohort will receive neoadjuvant therapy with an aromatase inhibitor or selective estrogen receptor modulator (SERM) for about 12…
- Trial name
- NCT06218303
- Testing
- MUC1 Peptide Vaccine, Hiltonol®, Aromatase Inhibitor
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Finn, Olivera, PhD
Breast Cancer
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
Study done in young breast cancer patients to prevent chemotherapy induced ovarian failure
- Trial name
- NCT00196846
- Testing
- Goserelin
- Where
- Germany
- Volunteers
- 62 people
- Sponsor
- GBG Forschungs GmbH
Lymphedema
Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)
Based upon the current state of science, the investigators are proposing to conduct a randomized clinical trial in which participants are randomized post-surgery to either BIS or circumferential (tape) measurements for follow-up…
- Trial name
- NCT02167659
- Testing
- 23-32 mmHg compression sleeve with gauntlet
- Where
- 10 sites in United States, Australia
- Volunteers
- 1,201 people
- Sponsor
- ImpediMed Limited
Lymphedema, Breast Cancer
To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast Cancer
Lymphedema is the Build-up of Lymph Fluid in the Body's Tissue Causing Chronic, Debilitating Swelling. This Commonly Occurs as a Result of a Disruption of the Lymphatic System During Lymph Node Dissection Surgeries.
- Trial name
- LYMPHA (NCT04328610)
- Testing
- LYMPHA(LYmphatic Microsurgical Preventive Healing Approach) technique
- Where
- South Korea
- Volunteers
- 34 people
- Sponsor
- Pusan National University Hospital
Breast Cancer
REaCT Integrated Consent Model to Compare Two Standard of Care Regimens
The Integrated Consent Model is being increasingly used internationally to improve patient care. In this feasibility study we will explore whether the model is feasible in practice; and whether it can be used to increase the…
- Trial name
- OTT14-03 (NCT02173262)
- Testing
- G-CSF, Ciprofloxacin
- Where
- Canada
- Volunteers
- 142 people
- Sponsor
- Ottawa Hospital Research Institute